These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1761419)
1. Antifungal and antiviral activities of benanomicins and their analogues. Kondo S; Gomi S; Ikeda D; Hamada M; Takeuchi T; Iwai H; Seki J; Hoshino H J Antibiot (Tokyo); 1991 Nov; 44(11):1228-36. PubMed ID: 1761419 [TBL] [Abstract][Full Text] [Related]
2. Isolation of new minor benanomicins. Kondo S; Gomi S; Uotani K; Inouye S; Takeuchi T J Antibiot (Tokyo); 1991 Feb; 44(2):123-9. PubMed ID: 2010353 [TBL] [Abstract][Full Text] [Related]
3. Pradimicins A, B and C: new antifungal antibiotics. II. In vitro and in vivo biological activities. Oki T; Tenmyo O; Hirano M; Tomatsu K; Kamei H J Antibiot (Tokyo); 1990 Jul; 43(7):763-70. PubMed ID: 2167304 [TBL] [Abstract][Full Text] [Related]
4. Syntheses and antifungal activities of novel 3-amido bearing pseudomycin analogues. Zhang YZ; Sun X; Zeckner DJ; Sachs RK; Current WL; Gidda J; Rodriguez M; Chen SH Bioorg Med Chem Lett; 2001 Apr; 11(7):903-7. PubMed ID: 11294388 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antifungal activities of BMS-181184. Oki T; Kakushima M; Hirano M; Takahashi A; Ohta A; Masuyoshi S; Hatori M; Kamei H J Antibiot (Tokyo); 1992 Sep; 45(9):1512-7. PubMed ID: 1429237 [No Abstract] [Full Text] [Related]
6. Antifungal agents from the roots of Cudrania cochinchinensis against Candida, Cryptococcus, and Aspergillus species. Fukai T; Yonekawa M; Hou AJ; Nomura T; Sun HD; Uno J J Nat Prod; 2003 Aug; 66(8):1118-20. PubMed ID: 12932139 [TBL] [Abstract][Full Text] [Related]
7. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole. Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030 [TBL] [Abstract][Full Text] [Related]
8. Investigation of aryl isonitrile compounds with potent, broad-spectrum antifungal activity. Mohammad H; Kyei-Baffour K; Younis W; Davis DC; Eldesouky H; Seleem MN; Dai M Bioorg Med Chem; 2017 Jun; 25(11):2926-2931. PubMed ID: 28385596 [TBL] [Abstract][Full Text] [Related]
9. Binding of benanomicin A to fungal cells in reference to its fungicidal action. Watanabe M; Gomi S; Tohyama H; Ohtsuka K; Shibahara S; Inouye S; Kobayashi H; Suzuki S; Kondo S; Takeuchi T; Yamaguchi H J Antibiot (Tokyo); 1996 Apr; 49(4):366-73. PubMed ID: 8642000 [TBL] [Abstract][Full Text] [Related]
10. Oxadiazolylthiazoles as novel and selective antifungal agents. Hagras M; Salama EA; Sayed AM; Abutaleb NS; Kotb A; Seleem MN; Mayhoub AS Eur J Med Chem; 2020 Mar; 189():112046. PubMed ID: 31962263 [TBL] [Abstract][Full Text] [Related]
11. Oryzachlorin, a new antifungal antibiotic. (Studies on antiviral and antitumor antibiotics. 18). Kato A; Saeki T; Suzuki S; Ando K; Tamura G J Antibiot (Tokyo); 1969 Jul; 22(7):322-6. PubMed ID: 5388123 [No Abstract] [Full Text] [Related]
12. [In vitro antifungal activity of micafungin]. Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275 [TBL] [Abstract][Full Text] [Related]
14. Total synthesis and biological evaluation of an antifungal tricyclic o-hydroxy-p-quinone methide diterpenoid. Huang J; Foyle D; Lin X; Yang J J Org Chem; 2013 Sep; 78(18):9166-73. PubMed ID: 23957833 [TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of benanomicins. Gomi S; Sezaki M; Hamada M; Kondo S; Takeuchi T J Antibiot (Tokyo); 1989 Jul; 42(7):1145-50. PubMed ID: 2753819 [TBL] [Abstract][Full Text] [Related]
16. New antifungal antibiotics, benanomicins A and B inhibit infection of T-cell with human immunodeficiency virus (HIV) and syncytium formation by HIV. Hoshino H; Seki J; Takeuchi T J Antibiot (Tokyo); 1989 Feb; 42(2):344-6. PubMed ID: 2784430 [No Abstract] [Full Text] [Related]
17. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559 [TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity of an antifungal antibiotic benanomicin A in comparison with amphotericin B. Watanabe M; Hiratani T; Uchida K; Ohtsuka K; Watabe H; Inouye S; Kondo S; Takeuchi T; Yamaguchi H J Antimicrob Chemother; 1996 Dec; 38(6):1073-7. PubMed ID: 9023656 [TBL] [Abstract][Full Text] [Related]
19. Generation of new benanomicin analogues by biotransformation using Escherichia coli expressing actinomycete cytochrome P450. Kumagai H; Umekita M; Sawa R; Takahashi Y; Arisawa A; Isshiki K; Nishimura Y; Akamatsu Y J Antibiot (Tokyo); 2008 Jun; 61(6):394-9. PubMed ID: 18667788 [TBL] [Abstract][Full Text] [Related]
20. Antifungal antibiotic benanomicin A increases susceptibility of Candida albicans to phagocytosis by murine macrophages. Watabe H; Mikuniya T; Inouye S; Abe S; Yamaguchi H; Kondo S; Takeuchi T; Klein TW; Friedman H; Yamamoto Y J Antibiot (Tokyo); 1996 Dec; 49(12):1221-5. PubMed ID: 9031667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]